Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1

Clara Cavelier1, Iris Lorenzi, Lucia Rohrer

  • 1Institute of Clinical Chemistry, University Hospital Zurich, University Zurich, Rämistrasse 100, CH 8091 Zurich, Switzerland.

Insights

High-density lipoproteins (HDL) and apolipoprotein A-I (apoA-I) protect against cardiovascular disease by removing cholesterol. This review examines how ABCA1 and ABCG1 transporters facilitate this process.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • High-density lipoproteins (HDL) and apolipoprotein A-I (apoA-I) levels correlate inversely with cardiovascular disease risk.
  • Atheroprotective mechanisms involve reverse cholesterol transport, where HDL and apoA-I remove excess cholesterol from foam cells.
  • ATP-binding cassette transporters ABCA1 and ABCG1 are crucial for lipid efflux from foam cells to apoA-I and HDL.

Purpose of the Study:

  • To review and discuss controversial aspects of ABCA1 and ABCG1 function in lipid transport.
  • To explore the direct interactions between apoA-I/HDL and ABCA1/ABCG1.
  • To investigate the role of retroendocytosis in cholesterol efflux mediated by these transporters.

Main Methods:

  • Literature review and critical analysis of existing research on ABCA1 and ABCG1.
  • Discussion of experimental evidence regarding transporter-ligand interactions.
  • Examination of proposed mechanisms for lipid removal and HDL formation.

Main Results:

  • The precise mechanisms of lipid removal by ABCA1 and ABCG1 remain incompletely understood.
  • Controversies exist regarding direct interactions between apoA-I/HDL and ABCA1/ABCG1.
  • The role of retroendocytosis in cholesterol efflux requires further clarification.

Conclusions:

  • ABCA1 and ABCG1 are critical for preventing lipid accumulation in macrophages and protecting arteries.
  • Further research is needed to elucidate the direct interactions, lipid specificities, and mechanistic details of ABCA1 and ABCG1 in reverse cholesterol transport.
  • Resolving these questions is essential for understanding atheroprotection and developing therapeutic strategies.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...